Sort   by:  
 Page size 
UnknownPhase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors.
Not available
S-EPMC7845944 | biostudies-literature
UnknownTranscriptional Silencing of MCL-1 Through Cyclin-Dependent Kinase Inhibition in Acute Myeloid Leukemia.
Not available
S-EPMC6920180 | biostudies-literature
UnknownTargeting hedgehog signaling in myelofibrosis and other hematologic malignancies.
Not available
S-EPMC3975838 | biostudies-literature
UnknownThe DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia.
Not available
S-EPMC6265654 | biostudies-literature
UnknownMolecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.
Not available
S-EPMC6369924 | biostudies-literature
UnknownEx vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies.
Not available
S-EPMC4331188 | biostudies-literature
UnknownPI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation.
Not available
S-EPMC3385948 | biostudies-literature
UnknownFunctional proteomic profiling of AML predicts response and survival.
Not available
S-EPMC2951831 | biostudies-literature
UnknownSafety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study.
Not available
S-EPMC6008465 | biostudies-literature
UnknownSafety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
Not available
S-EPMC7387307 | biostudies-literature
Sort   by:  
 Page size